Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Enzalutamide in Prostatic Cancer: NCT07783282 Clinical Landscape Report 2026
16 September 2026
NCT07783282 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT07779343 Clinical Landscape Report 2026
16 September 2026
NCT07779343 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tirzepatide in Non-Small Cell Lung Cancer: NCT07782359 Clinical Landscape Report 2026
16 September 2026
NCT07782359 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VGT-309 in Pancreatic Ductal Adenocarcinoma: ACTRN12626001037392 Clinical Landscape Report 2026
16 September 2026
ACTRN12626001037392 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
Mecobalamin in Kidney Failure, Chronic: NCT07781020 Clinical Landscape Report 2026
16 September 2026
NCT07781020 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NXP-900 in ALK positive Lung Cancer: NCT07784959 Clinical Landscape Report 2026
16 September 2026
NCT07784959 clinical landscape for ALK positive Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Camrelizumab in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07787273 Clinical Landscape Report 2026
16 September 2026
NCT07787273 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Recombinant meningococcal group B vaccine (Sanroad Biological Products) in Hepatitis B: NCT07784452 Clinical Landscape Report 2026
16 September 2026
NCT07784452 clinical landscape for Hepatitis B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GZC8072 in Obesity: NCT07784699 Clinical Landscape Report 2026
16 September 2026
NCT07784699 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MWN-109 in Diabetes Mellitus: NCT07787728 Clinical Landscape Report 2026
16 September 2026
NCT07787728 clinical landscape for Diabetes Mellitus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Roxadustat in Anemia: NCT07786168 Clinical Landscape Report 2026
16 September 2026
NCT07786168 clinical landscape for Anemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cetuximab in BRAF V600 mutant Colorectal Cancer: NCT07790510 Clinical Landscape Report 2026
16 September 2026
NCT07790510 clinical landscape for BRAF V600 mutant Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…